Jaume Mora

18PUBLICATIONS
54CO-AUTHORS
Radiation therapyCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 25, 2024
Current Status of Fertility Preservation in Pediatric Oncology Patients.

Albert Pasten González, Cristina Salvador Alarcón, Jaume Mora

|May 11, 2024
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy.

Maite Gorostegui, Juan Pablo Muñoz, Sara Perez-Jaume

|Oct 10, 2023
Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma.

Rosario Aschero, Daiana Ganiewich, Gabriela Lamas

|Jul 29, 2023
Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2.

Cristina Larrosa, Jaume Mora, Nai-Kong Cheung

Pageof 3